Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Tiseo

Showing results (31-40 of 363) with videos related to

Pageof 37
Sort By:
Immunotherapy|July 20, 2019
Advances in the prediction of long-term effectiveness of immune checkpoint blockers for non-small-cell lung cancerSara Elena Rebuzzi, Alessandro Leonetti, Marcello Tiseo, et al.
Advances in Anatomic Pathology|August 14, 2013
Is immunohistochemistry always required to diagnose lung cancer?Giulio Rossi, Marcello Tiseo, Alberto Cavazza, et al.
Current Drug Targets|January 14, 2016
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case ReportMelissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, et al.
Case Reports in Ophthalmology|May 31, 2021
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with GefitinibFabrizio Gozzi, Marcello Tiseo, Francesco Facchinetti, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Tumori|February 24, 2015
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADHPaola Bordi, Marcello Tiseo, Sebastiano Buti, et al.
Immunotherapy|February 8, 2019
Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?Francesco Facchinetti, Maria Majori, Mariangela Sabato, et al.
Anti-Cancer Drugs|January 10, 2020
A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?Melissa Bersanelli, Sebastiano Buti, Antonio Ghidini, et al.
The Lancet. Oncology|July 4, 2014
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?Sebastiano Buti, Melissa Bersanelli, Marcello Tiseo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2014
Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecanMarcello Tiseo, Sebastiano Buti, Luca Boni, et al.
Pageof 37

Showing results (31-40 of 363) with videos related to

Sort By:
Pageof 37
Immunotherapy|July 20, 2019
Advances in the prediction of long-term effectiveness of immune checkpoint blockers for non-small-cell lung cancerSara Elena Rebuzzi, Alessandro Leonetti, Marcello Tiseo, et al.
Advances in Anatomic Pathology|August 14, 2013
Is immunohistochemistry always required to diagnose lung cancer?Giulio Rossi, Marcello Tiseo, Alberto Cavazza, et al.
Current Drug Targets|January 14, 2016
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case ReportMelissa Bersanelli, Francesco Facchinetti, Marcello Tiseo, et al.
Case Reports in Ophthalmology|May 31, 2021
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with GefitinibFabrizio Gozzi, Marcello Tiseo, Francesco Facchinetti, et al.
Drug Design, Development and Therapy|September 22, 2018
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectivesFrancesco Facchinetti, Paola Bordi, Alessandro Leonetti, et al.
Tumori|February 24, 2015
Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADHPaola Bordi, Marcello Tiseo, Sebastiano Buti, et al.
Immunotherapy|February 8, 2019
Early fatal hemoptysis after first-dose, first-line pembrolizumab in a central lung cancer: did tumor shrinkage matter?Francesco Facchinetti, Maria Majori, Mariangela Sabato, et al.
Anti-Cancer Drugs|January 10, 2020
A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?Melissa Bersanelli, Sebastiano Buti, Antonio Ghidini, et al.
The Lancet. Oncology|July 4, 2014
BOLERO-3 results: pharmacological activity or pharmacokinetic effect?Sebastiano Buti, Melissa Bersanelli, Marcello Tiseo, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2014
Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecanMarcello Tiseo, Sebastiano Buti, Luca Boni, et al.
Pageof 37